Literature DB >> 22262606

A systematic review of validated methods for identifying pancreatitis using administrative data.

Kevin Moores1, Bradley Gilchrist, Ryan Carnahan, Thad Abrams.   

Abstract

PURPOSE: To systematically review algorithms identifying cases of pancreatitis in administrative data, with a focus on studies examining algorithm validity.
METHODS: A literature search was conducted using PubMed and the Iowa Drug Information Service database. Reviews were conducted by two investigators identifying studies using data sources from the USA or Canada. These data sources most likely reflect the coding practices of Mini-Sentinel data partners.
RESULTS: Eight studies were obtained examining the validity of an algorithm to identify pancreatitis in either hospital or ambulatory medical records or billing databases. The best-performing algorithm was International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM) code 577.0; with a positive predictive value of 60%-80% and a negative predictive value usually greater than 90%. Populations involved in different studies were heterogeneous; age ranges, level of population risk, pancreatitis etiology, and geographic distribution were highly variable.
CONCLUSIONS: Validation studies find that the principal ICD-9-CM diagnosis code of 577.0 had the best positive predictive value and specificity. Current studies do not support the use of the ICD-9-CM codes 577.1 and 577.2. Databases enhanced with laboratory values at point of care would invariably increase the specificity of existing algorithms.
Copyright © 2012 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Year:  2012        PMID: 22262606     DOI: 10.1002/pds.2334

Source DB:  PubMed          Journal:  Pharmacoepidemiol Drug Saf        ISSN: 1053-8569            Impact factor:   2.890


  6 in total

1.  Acute pancreatitis in patients with type 2 diabetes mellitus treated with dipeptidyl peptidase-4 inhibitors: a population-based nested case-control study.

Authors:  Hsin-Chun Chou; Wen-Wen Chen; Fei-Yuan Hsiao
Journal:  Drug Saf       Date:  2014-07       Impact factor: 5.606

2.  Chronic Pancreatitis Patients Who Leave Against Medical Advice: Prevalence, Trend, and Predictors.

Authors:  Olalekan Akanbi; Adeyinka Charles Adejumo; Mohanad Soliman; Praneeth Kudaravalli
Journal:  Dig Dis Sci       Date:  2020-05-02       Impact factor: 3.199

3.  Adverse gastrointestinal events with intravitreal injection of vascular endothelial growth factor inhibitors: nested case-control study.

Authors:  Robert J Campbell; Chaim M Bell; Susan E Bronskill; J Michael Paterson; Marlo Whitehead; Erica de L Campbell; Sudeep S Gill
Journal:  Drug Saf       Date:  2014-09       Impact factor: 5.606

4.  The Risk of Acute Pancreatitis After Initiation of Dipeptidyl Peptidase 4 Inhibitors: Testing a Hypothesis of Subgroup Differences in Older U.S. Adults.

Authors:  Jin-Liern Hong; John B Buse; Michele Jonsson Funk; Virginia Pate; Til Stürmer
Journal:  Diabetes Care       Date:  2018-04-04       Impact factor: 19.112

5.  Rapid, responsive, relevant (R3) research: a call for a rapid learning health research enterprise.

Authors:  William T Riley; Russell E Glasgow; Lynn Etheredge; Amy P Abernethy
Journal:  Clin Transl Med       Date:  2013-05-10

6.  Amiodarone use and the risk of acute pancreatitis: Influence of different exposure definitions.

Authors:  Mirjam Hempenius; Rolf H H Groenwold; Anthonius de Boer; Olaf H Klungel; Helga Gardarsdottir
Journal:  Pharmacoepidemiol Drug Saf       Date:  2019-08-02       Impact factor: 2.890

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.